FIELD: medicine.
SUBSTANCE: 12 hours prior to operation low-molecular heparin Sodium Enoxaparine (Clexane) is hypodermically introduced in dose 1 mg/kg of body weight. Within the first hour after operation injection is repeated. Then Sodium Enoxaparine is injected in the same dose every 12 hours within 5 days after operation. Solution Berlytione® 300 is continuously intravenously used as antioxidant in the first 24 o'clock after operation in daily dose 600 mg.
EFFECT: allows for prevention of reperfusion syndrome development.
1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREVENTION OF REPERFUSION COMPLICATIONS IN PATIENTS SURGERY FOR ACUTE LOWER LIMB ISCHEMIA | 2021 |
|
RU2778351C1 |
| HEPARIN OF AVERAGE MOLECULAR WEIGHT | 2000 |
|
RU2322245C2 |
| METHOD OF PREVENTING INFLAMMATORY AND THROMBOEMBOLIC COMPLICATIONS AFTER CESAREAN SECTION OPERATION IN WOMEN FROM HIGH RISK GROUP | 2009 |
|
RU2418595C1 |
| METHOD OF TREATING PYOINFLAMMATORY DISEASES AND PREVENTION OF LOCAL NECROTIC AND SEPTICOPYEMIC COMPLICATIONS IN CHILDREN | 2007 |
|
RU2383347C2 |
| METHOD FOR CARE OF PATIENTS WITH ACUTE CORONARY SYNDROME UNDER CONDITIONS OF MEDICAL INSTITUTION WITH SPECIALIZED DEPARTMENT OF PERCUTANEOUS CORONARY INTERVENTIONS | 2015 |
|
RU2641851C2 |
| PERSONALIZED METHOD OF TREATING VEIN THROMBOSIS OF LOWER EXTREMITIES IN WOUNDED | 2023 |
|
RU2813947C1 |
| METHOD FOR CORRECTING STRESS-INDUCED HEMOSTASIS SYSTEM CHANGES CAUSED BY SURGICAL INTERVENTIONS IN METABOLIC SYNDROME CASES | 2005 |
|
RU2297220C2 |
| METHOD FOR ANTICOAGULANT THERAPY AND PREVENTION OF THROMBOTIC COMPLICATIONS IN PATIENTS WITH SEVERE BRAIN DAMAGE IN A CHRONIC CRITICAL CONDITION | 2021 |
|
RU2762945C1 |
| AGENT WITH ANTICOAGULATING EFFECT AND ITS APPLICATION METHOD | 2021 |
|
RU2799028C2 |
| METHOD OF TREATING PATIENTS WITH SEVERE FORMS OF REPERFUSION SYNDROME | 2023 |
|
RU2807877C1 |
